Coming off a GLP-1: how to keep the weight off after Ozempic, Wegovy or Mounjaro

One boundary first: this is not medical advice

Nothing here tells you whether, when or how to stop a medication. That decision belongs to you and the doctor who prescribed it — never to an article, and never to an app. Staying on treatment long term is a legitimate, common and often medically sensible path; obesity is treated as a chronic condition, not a 12-week project.

What this article covers is the layer underneath the medication: the eating and movement behaviour that has to carry your weight whenever the drug is not doing it. That layer is worth building either way.

What the trials actually show

The STEP 1 extension followed 327 people for a year after both semaglutide and the accompanying lifestyle support were withdrawn. On average they had lost about 17 % of their body weight; in the year off the drug they regained roughly two-thirds of it. The improvements in blood pressure and blood lipids largely reverted along with the weight (Wilding et al., 2022).

SURMOUNT-4 tested the same question as a proper randomised withdrawal: 670 people took tirzepatide for 36 weeks, then half continued and half switched to placebo. Those who continued kept losing. Those who switched regained a substantial share of what they had lost within a year (Aronne et al., 2024).

Read honestly, this says something narrow and important: the medication works while you take it. Regain after stopping is a predictable pharmacological result, not evidence that you failed. But it also means the plan for “after” cannot be “I will just be careful”.

Why the weight comes back

Your appetite was suppressed, not reset

The drug works largely by making you less hungry and full sooner. That effect fades with the drug — the appetite you had before was never renegotiated, only paused. Many people describe the return of “food noise” within weeks of the last dose.

A lighter body needs less energy

This applies after every weight loss, drug or not: you now weigh less, so you burn less. Going back to the way you ate before your loss is a surplus at your new weight, even though it was maintenance at your old one. The mechanism is in Calorie deficit explained.

Part of what you lost was muscle

In rapid weight loss a meaningful share of the loss is lean mass, and GLP-1 trials are no exception — a review of the body-composition data puts it in the same range as other rapid weight-loss interventions and names the two mitigations: enough protein and resistance training (Neeland et al., 2024). This matters because regained weight is mostly fat. Lose muscle, gain back fat, and you end up at the same number on the scale with a worse body composition and a lower energy expenditure than you started with.

The habits were never built

This is the one nobody warns you about. When the medication does the portion control for you, you can lose 20 kilos without ever learning what a maintenance-sized plate looks like, without building a single routine, and without a way to read your own progress. The weight went; the skills never arrived. That is the gap that has to be closed on purpose.

The maintenance stack: build this before the last dose

Everything below is easier now than it will ever be again, because your appetite is currently on your side. Treat the time on the medication as training time, not just losing time.

1. 1Protein at every meal, deliberately. With a suppressed appetite, protein does not happen by accident — you have to plan it. A palm-sized portion at each main meal is the practical target; the reasoning is in Protein for weight loss, and the wider problem of eating too little is in not eating enough on a GLP-1.
2. 2Resistance training twice a week. Alongside protein this is the intervention with actual evidence behind it for keeping muscle during weight loss. Two short full-body sessions beat an ambitious plan you drop.
3. 3A portion rule that works without the drug. Learn to size a plate by hand: a palm of protein, a fist or two of vegetables, a cupped hand of carbohydrates, a thumb of fat. Your hand scales with your body and still works on the day the appetite suppression does not.
4. 4Daily weigh-ins and a smoothed trend. This is your early-warning system for the year after. Set it up now, while the line is going the right way, so reading it is already routine — see Why the scale swings every day.
5. 5Two or three anchored habits. Not ten. Attach them to fixed points in your day so they run without decisions, the way habits rather than willpower are meant to.

Rehearse maintenance while you still have a safety net

Here is the single most useful thing you can do in the last months on the medication: stop treating the dose as the plan and start eating as if you were already off it. Portion by hand, hit your protein, keep the habits — and let the drug be the safety net rather than the driver.

It works for the same reason a fire drill works. You find out where your plan is thin — the work lunches, the weekends, the evenings — at a moment when the cost of finding out is nearly zero.

The first 90 days after

1. 1Define a maintenance zone, not a number. Two to three kilos wide around the weight you reached. Inside the zone, nothing to do. The full logic is in How to avoid yo-yo dieting.
2. 2Check the trend once a week, not the daily number. A single reading after a salty dinner means nothing; four weeks of drift means something.
3. 3Act at the top edge of the zone, not five kilos later. Reach for your two or three proven habits for a couple of weeks. Small corrections early beat another round of dieting.
4. 4Expect the food noise to return, and have an answer ready. Write your if-then plan for the evening urge before it arrives — see How to stop emotional eating.
5. 5Never miss twice. One bad weekend is an event. Two in a row is the beginning of the old pattern.

This is precisely the phase Habituaria is built for: not the fast loss, but the habits, the hand portions and the smoothed trend that hold the result afterwards — including a maintenance mode for the time after your goal.